BURNING ROCK BIOTECH LTD. Products & Brands - Key Offerings and Insights

Products

Category

Product

Brand

Description

Multi-Cancer Diagnostic Tests: Global Market Outlook (MDS101A)

OverC multi-cancer early detection test

It is an NGS-based multi-cancer early detection test. The product has completed proof-of-concept R&D and moved into the clinical validation stage. In May 2022, Burning Rock received a CE mark for OverC manufactured in the U.S. and China facilities.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.